Soft drugs. 2. Soft alkylating compounds as potential antitumor agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Development of novel anticancer agents is crucial for combating cancer.
• Soft alkylating compounds represent a promising class of chemotherapeutic agents.
• Existing methods for evaluating alkylating reactivity may lack sensitivity or reproducibility.

Purpose of the Study:

• To synthesize and characterize a new class of soft alkylating compounds.
• To develop a sensitive and reproducible method for quantifying alkylating reactivity.
• To evaluate the anticancer potential of selected soft alkylating agents.

Main Methods:

• Synthesis of alpha-halo esters of various carboxylic acids.
• Development of a competitive alkylation reaction assay.
• Quantitative analysis of reaction mixtures using Nuclear Magnetic Resonance (NMR) spectroscopy.

Main Results:

• Successful synthesis of a series of soft alkylating compounds, including alpha-halo esters.
• Establishment of a sensitive and reproducible competitive alkylation method for reactivity assessment.
• Identification of chloromethyl hexanoate as a soft alkylating agent exhibiting anticancer activity.

Conclusions:

• Soft alkylating compounds, specifically alpha-halo esters, are viable candidates for anticancer drug development.
• The developed NMR-based competitive alkylation assay is effective for evaluating alkylating agent reactivity.
• Chloromethyl hexanoate warrants further investigation as a potential anticancer therapeutic.